October 28, 2008--CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied ...
From a solo flight around the world in his single-engine plane to starting a foundation that protects endangered coral reefs, Lyle Turner has seldom sat still in the decade since he retired from ...
Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the ...
We’ll send you a myFT Daily Digest email rounding up the latest US & Canadian companies news every morning. Invitrogen, a US biotechnology company, is to merge with rival Applied Biosystems in a ...
In 1987, three local researchers gathered in an Encinitas garage with an idea that, 26 years later, is worth $13.6 billion. The garage belonged to Lyle Turner, who got together with partners Joe ...
Accurate and efficient data analysis of protein targets is an integral part of the gel and western blot imaging workflow. The Invitrogen iBright Analysis Software is an optimized software application ...
Invitrogen (www.invitrogen.com), supplier of reagents and tools for gene and protein research for 20 years, is expanding its product lines and moving toward cell biology. In the past few years, ...
Aga2-fusion protein binding to yeast cell by Aga1. Image provided by Invitrogen. Phage display systems, reviewed in a recent issue of The Scientist, 1 have proven enormously useful for the detection ...
President and COO of Applied Biosystems Answers GEN’s Questions about the Merger I recently attended a press event where the joint venture between Applied Biosystems (AB) /MDS Analytical Technologies ...
SAN FRANCISCO (MarketWatch) -- Invitrogen Corp. said after the closing bell on Tuesday that James Glynn, chief executive officer emeritus, plans to retire as a director at the annual shareholder ...
NEW YORK/BOSTON (Reuters) - Invitrogen Corp plans to buy Applied Biosystems Inc for $6.7 billion to form a top provider of research tools for the life sciences industry, the companies said on Thursday ...